Baseline clinical and angiographic features of the study population according to treatment
| TA (N=150) | SP (N=149) | p | |
| Age (mean±SD) | 60±11 | 60±10 | 0.77 |
| Sex (M), n (%) | 125 (83) | 113 (76) | 0.11 |
| Diabetes, n (%) | 24 (16) | 19 (13) | 0.42 |
| Failed TL, n (%) | 21 (14) | 21 (14) | 0.98 |
| IIb/IIIa inhibitors, n (%) | 70 (47) | 67 (45) | 0.76 |
| Time to treatment (min) (mean±SD) | 220±125 | 246±173 | 0.12 |
| MVD, n (%) | 65 (43) | 51 (34) | 0.11 |
| LAD as infarct related artery, n (%) | 61 (41) | 69 (46) | 0.32 |
| Baseline TIMI flow 0–1, n (%) | 132 (88) | 131 (88) | 0.98 |
| Baseline TS 3–5, n (%) | 100 (67) | 85 (57) | 0.09 |
| RVD (mm) (mean±SD) | 3.19±0.44 | 3.13±0.44 | 0.18 |
| Lesion length (mm) (mean±SD) | 21.85±9.69 | 21.42±8.40 | 0.68 |
LAD, left anterior descending artery; MVD, multivessel disease; RVD, reference vessel diameter; SP, standard PCI; TA, thrombus aspiration; TL, thrombolysis; TS, thrombus score.